PembrolizumabHypothyroidism, off-label-use and lack-of-efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1920卷 / 1期

关键词：

D O I：

10.1007/s40278-022-21934-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：397 / 397

相关论文

共 50 条

[1] Multiple drugsDrug resistance, off-label-use and lack of efficacy: case report
[J]. Reactions Weekly, 2022, 1931 (1) : 389 - 389
[2] Multiple drugsVarious toxicities, lack-of-efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1883 (1) : 283 - 283
[3] Multiple drugsVarious toxicities following off-label use and lack-of-efficacy: case report
[J]. Reactions Weekly, 2021, 1837 (1) : 487 - 487
[4] Methylprednisolone\remdesivirLack of efficacy and off-label-use: case report
[J]. Reactions Weekly, 2022, 1922 (1) : 385 - 385
[5] Multiple drugLack of efficacy and off-label-use: case report
[J]. Reactions Weekly, 2022, 1936 (1) : 313 - 313
[6] Multiple drugsLack of efficacy and off-label-use: case report
[J]. Reactions Weekly, 2021, 1881 (1) : 179 - 179
[7] AntineoplasticsVarious toxicities, lack of efficacy and off-label-use: 2 case reports
[J]. Reactions Weekly, 2022, 1936 (1) : 73 - 73
[8] Antineoplastics/Lutetium-177-psma-imaging-and-therapyFatigue, lack of efficacy and off-label-use: case report
[J]. Reactions Weekly, 2023, 1942 (1) : 49 - 49
[9] Hydroxychloroquine/lopinavir/ritonavirLack of efficacy following off-label-use: case report
[J]. Reactions Weekly, 2022, 1926 (1) : 252 - 252
[10] RituximabNeutropenia following off-label-use: case report
[J]. Reactions Weekly, 2019, 1776 (1) : 396 - 396

← 1 2 3 4 5 →